How Does Dr. Clay Siegall Lead Seattle Genetics?

There are a lot of people out there creating drugs for the marketplace, and one of the best companies for this is Seattle Genetics. Dr. Clay Siegall has his doctorate in genetics, and he has been working on drugs based on antibodies for cancer patients. His work has helped to save a lot of lives, and it is proving to be very successful because of the sales his company has achieved.

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript

There have been nearly $100 million in sales on cancer drugs from Seattle Genetics, and they are getting their drugs to a lot of people who need them. Doctors only buy the drugs that work, and that is why the drug trials from Seattle Genetics have been so successful. They are making something that is proving to work on more than one kind of cancer.

Seattle Genetics is trying to be as good as it can be at the two drugs it has going today that it will be able to make other cancer drugs in the past. The genetic work that has been done by Dr. Clay Siegall and his team is incredible because it has tangible results that anyone would be able to see. This means that all the people who take their drugs have a better chance of surviving, and it also shows people that there is another way to make the drugs for the future.

The drug industry has been overfilled with companies all doing things the same way, and now they are going to start doing things in a new way that works. They have the sales to prove that something is working, and they also have patients who are surviving. Treating more than one type of cancer is something that all the drug companies in the industry should hope they will be able to do.w

Securus: They Won’t Stand For It Anymore

There comes a time where enough is enough and there needs to be serious changes. You never know when that point is going to hit or how it is going to happen, but when it happens, you need to act swiftly and you need to act right away. When you have decided that this has gone on for too long and no one has done anything about it, it is very difficult to stand by and watch it happen. When you are a company like Securus, which has a high moral fiber, you don’t take kindly to these sorts of things that are happening with GTL.

Get the latest news on Linkedin about Securus.

Let me give you a little background on what is happening so you understand. Securus is a provider of civil and criminal justice technology solutions for public safety, investigation, corrections and monitoring. Global Tel-Link or GTL, as they are sometimes referred to, are an inmate communications provider. GTL has been taking advantage of customers, ripping them off, and using very deceitful methods of business.

Now, Securus is doing something about it and they are striking back and fighting against them. They are releasing a series of press releases, which will expose the company for all of their wrongdoings and integrity breaches, as they have called it. These press releases will show the world what GTL is all about and how they operate. These are facts, so they are backing it up with true-to-life facts and taking it right to them. They have had enough of their actions and they are going to let the entire world know what GTL has been up to lately.

Securus Video Visitation Christmas from Securus Technologies on Vimeo.

Stephen Murray had a brilliant career

The economy is rapidly recovering, and many businesses are looking for examples of brilliant leadership. They want to give their workers inspiration, and they want their company to reach new heights.

There are many brilliant examples of leadership throughout the finance industry, but Stephen Murray is one of the greatest examples. He passed away recently, but throughout Stephen’s career, he had a dramatic impact on the finance world.

Stephen Murray was born in the Northeastern United States. Throughout his time in school, Stephen was considered a brilliant child who had great potential. His teachers were very impressed, and he easily earned a spot at Boston College.

Stephen continued his excellence at Boston College, and when he graduated he was hired by Manufacturers Hanover Corporation.

After receiving his MBA from Columbia, Stephen Murray was shifted to MH Equity Corporation, Manufacturers Hanover Corporation’s private equity group. Stephen had a major impact on the company because he was a brilliant man and a hard worker. It was a chaotic time for the finance industry and the company ended up merging with Chemical Bank. Chemical Bank quickly merged with Chase Manhattan Corporation.

Chase experienced multiple mergers throughout this time, and eventually became JP Morgan Chase. The company continued to grow, and Stephen grew with it. Stephen had an impressive career at JP Morgan, and he was a great candidate for leadership. When JP Morgan started to spinoff their divisions he was a great candidate for leadership at CCMP Capital.

Stephen became CEO of CCMP Capital in 2007, and he immediately capitalised on the situation. He helped build the firm into a major power. The firm now has $12 billion invested.

They are the 17th largest private equity firm in the world. Stephen was heavily involved in the daily operations of the fund, and when he died in 2015 the company was in great shape. He is remembered well throughout the company.  Learn more about Stephen Murray CCMP Capital:

Stephen Murray CCMP Capital had a tremendous impact on the finance industry. His career started during a chaotic period for finance, but he managed to work his way up the ladder regardless.

He made a major impression on everyone he worked for, and he loved working as the head of CCMP Capital. The fact that CCMP Capital is a major player in the financial world is a testament to Stephen Murray’s brilliance.